CeQur

MedGadget, June 2013: Continued Advancement for Diabetic Therapies – An Interview with CeQur SVP Jay Warner

CeQur Senior Vice President of Commercialization discusses why there is a substantial need for simple insulin delivery devices like PaQ, why PaQ is different than other insulin delivery and mentions the clinical data that has and will be released and future plans for the device.
To read the article, click here.

OneMedPlace, March 2013: Novel, Minimally Invasive Drug Delivery Platform for Continuous Administration of Insulin Indicated for Type 2 Diabetes.

In a video interview CeQur CEO Jim Peterson discusses the challenges of people with type 2 to manage daily insulin injections, how PaQ works to deliver insulin and investment opportunity.
To read the article, click here.

Start Up magazine, January 2010: CeQur makes the "A-List"

In this review of the 2009 biopharma financing environment, Start Up writers Christopher Morrison and Tom Salemi selected CeQur from among the 60 Series A financings that occurred last year as one of just 13 they consider "trend-shaping". Morrison and Salemi note that CeQur and its 12 "A-list" peers are companies to "keep an eye on in 2010 and beyond."
To read the article, click here.

Massachusetts Medical Device Journal, January 2010: Q&A with CeQur CEO Jim Peterson

CeQur CEO Jim Peterson discusses his personal ties to diabetes technologies, why CeQur is poised to be the leader in next-generation insulin delivery devices, and why the CeQur PaQ insulin infuser will provide a unique, simple solution to many of the treatment challenges faced by people with type II diabetes.
To read the article, click here.